Business
Bioasis Welcomes John E. Curran & David M. Wurzer to the Company’s Board of Directors
Bioasis Welcomes John E. Curran & David M. Wurzer to the Company’s Board of Directors.
About this update from Bioasis Technologies Inc.
[{"type":"text","content":"\n \n BIOASIS \n TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF) (“Bioasis” or \n the “Company”), a biopharmaceutical company developing its xB3 \n TM proprietary platform technology for the delivery of \n therapeutics across the blood-brain barrier (BBB) for the treatment of \n central nervous system (CNS) disorders, today announced the appointments \n of John E. Curran, CPA and David M. Wurzer, CPA to the Bioasis Board of \n Directors, filling two of the current vacancies on the board. Mr. Curran \n recently retired from Deloitte \n & Touche LLP where he served as a partner in Hartford, Conn., \n United States. Mr. Wurzer is currently an executive vice president and \n chief investment officer at Connecticut \n Innovations in Rocky Hill, Conn., United States.\n \n\nThis press release features multimedia. View the full release here: \nhttps://www.businesswire.com/news/home/20180727005276/en/\n\n \n \n David M. Wurzer, CPA, executive vice president and chief investment officer, Connecticut Innovations (Photo: Business Wire) \n\n\n \n Director Maha Radhakrishnan, M.D. has resigned due to personal reasons, \n effective immediately.\n \n \n “We are very happy to welcome Dave and John to our board. They bring \n significant financial, board and audit and compensation committee \n expertise and their acceptance of these appointments supports the \n Company’s strategic business plans. Bioasis will benefit from their \n business acumen and counsel as the management team works to advance the \n Company with guidance from the board,” said Dr. Deborah Rathjen, chair \n of the board. “We would also like to thank Dr. Maha Radhakrishnan for \n her service and contributions to the board and wish her the very best.”\n \n \n In connection with the changes to the board, the composition of the \n board committees has been revised as follows:\n \n \n \n Audit Committee (fully comprised of independent directors): Mr. \n John E. Curran, CPA (chair), Dr. Deborah Rathjen and Mr. David M. \n Wurzer, CPA\n \n \n Compensation Committee (fully comprised of independent \n directors): Dr. Nancy Stagliano, Dr. Deborah Rathjen and Mr. David M. \n Wurzer, CPA\n \n \n \n “John and Dave have uncompromised standards for corporate governance and \n have displayed brilliant financial, operati...